Regional_chemotherapy_using_continuous_intravesical_infusion_doxorubicin_for_the_treatment_of_muscle_invasive_transitional_cell_bladder_carcinoma_in_a_rat_model._Previously_established_animal_models_of_invasive_transitional_cell_bladder_carcinoma_and_continuous_infusion_intravesical_drug_delivery_were_combined_to_evaluate_the_urothelial_toxicity_and_antineoplastic_efficacy_of_continuous_intravesical_infusion_doxorubicin_(DOX)._Dose-response_toxicity_experiments_studied_histologic_changes_in_the_rat_urinary_bladder_following_urothelial_exposure_to_three_different_urinary_levels_of_DOX,_as_a_function_of_the_duration_of_drug_infusion._Systemic_and_local_drug_absorption,_as_measured_by_DOX_levels_in_serum,_bladder,_retroperitoneal_lymph_nodes,_and_liver,_was_measured_at_intervals_during_drug_administration._In_vitro_chemosensitivity_assays_were_used_to_determine_tumor_sensitivity_to_DOX._Treatment_studies_evaluated_the_impact_of_14-day_continuous_infusion_DOX_beginning_seven_days_following_tumor_implantation._No_histologically_discernable_changes_in_the_normal_urothelium_were_noted_in_bladders_of_animals_receiving_continuous_intravesicle_DOX_at_mean_urinary_concentrations_of_0.05_micrograms./ml._(n_=_5),_0.56_micrograms./ml._(n_=_10),_and_5.69_micrograms./ml._(n_=_10)_for_periods_of_up_to_14_days._Serum_drug_concentrations_demonstrated_a_non-significant_upward_trend_following_the_start_of_therapy._Significant_increases_in_tissue_DOX_levels_were_noted_in_the_bladder_and_retroperitoneal_lymph_nodes_on_chemotherapy_days_7_and_14._Mean_tissue_DOX_concentrations_in_both_the_bladder_and_lymph_nodes_were_greater_than_the_IC50_observed_in_the_in_vitro_sensitivity_assay._DOX-treated_tumor-bearing_animals_(n_=_17)_had_a_mean_tumor_volume_(+/-_standard_deviation)_of_0.65_gm._+/-_0.52_gm._compared_to_an_average_tumor_volume_of_1.20_gm._+/-_0.66_gm._in_the_control_group_(n_=_18)_(p_=_0.0112)._Continuous_infusion_intraluminal_chemotherapy_demonstrated_a_clear_cytoreductive_effect_with_minimal_local_toxicity_in_this_model._Drug_tissue_levels_were_observed_in_regional_lymphatic_drainage_fields_as_well_as_the_bladder_wall._Further_study_to_evaluate_this_approach_as_a_bladder-sparing_alternative_to_muscle_invasive_disease_is_warranted.